Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2results about How to "Achieve high specificity detection" patented technology

Use of raman spectroscopy marker combination in preparation of diabetic foot osteomyelitis diagnosis product

This application provides an application of a Raman spectroscopy biomarker combination in the preparation of diagnostic products for diabetic foot osteomyelitis, belonging to the field of biomedical detection technology. The biomarker combination includes a first type of characteristic spectrum showing a significant increase in intensity or intensity ratio in positive samples of diabetic foot osteomyelitis compared to negative samples, and a second type of characteristic spectrum showing a significant decrease in intensity; specifically involving 1070 cm⁻¹. ‑1 With 1450 cm ‑1 The strength ratio, (851+873+917) cm ‑1 Region and 1656 cm ‑1 The strength ratio, and 960 cm ‑1 1001 cm ‑1 1103 cm ‑1 1450 cm ‑1 1590 cm ‑1 1656 cm ‑1 The intensity of multiple characteristic wavelengths was measured. The diagnostic model constructed based on this combination demonstrated good discrimination performance in testing. The method provided in this application has the advantages of being rapid and low-cost, offering a new solution for the early screening and auxiliary diagnosis of diabetic foot osteomyelitis.
Owner:AIR FORCE MEDICAL CENT PLA

Novel Csx biological pore protein monomer and application thereof

The invention discloses a novel Csx bioporous protein monomer and application thereof, in particular to application in detection of a DNA-peptide fragment, and relates to the technical field of gene sequencing, the invention further designs a DNA joint with a hairpin structure, the DNA joint comprises a template chain, a blocking chain and a primer chain, and the DNA-peptide fragment, the Csx bioporous protein is derived from Prevotella buccal bacteria, and the DNA-peptide fragment is derived from the Csx bioporous protein monomer. And cloning, expressing and purifying the haplotype Csx bioporous protein by using a gene recombination technology. The Csx biopore protein is derived from bacteria, is in a monomer form and is easy for protein assembly of biological nanopores, Csx cloning expression and purification processes are simple, and the cost is saved; the DNA-peptide fragment hairpin structure can be used for detecting DNA and peptide fragments, and provides a direction for developing application of detecting the peptide fragments.
Owner:HENAN HUAZHIYUAN INTELLIGENT MANUFACTURING TECHNOLOGY CO LTD